Unichem Laboratories enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


3,441	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
289	289	89.6	152	185
469	469	430	219	297
3,620	—	—	—	—
179	179	340	66.9	112
₹514.27	—	—	—	—

3,186	3,186	2,881	2,582	2,733
14.7%	14.7%	14.9%	8.5%	10.9%
0.13×	—	—	—	—

1.57×	—	—	—	—
15.84×	—	—	—	—
34.38×	—	—	—	—
2,308	2,202	2,111	1,705	1,343
229	184	265	100	−45.6
105	59.1	140	−13.0	−159
—	3.6	−7.0	16.7	−85.1
−119	−119	−144	−5.9	−129
—	−123	−147	−5.9	−129
—	123	137	22.5	44.3

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

UNICHEMLAB₹488.80

Unichem Laboratories Limited

· Pharma & Health

₹ CrorePeersGUFICBIO RPGLIFE GUJTHEM SMSPHARMA ORCHPHARMA INDSWFTLAB SOLARA FDCMcap ₹3,441 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	3,441.2
- Cash, Equiv & ST Investments	185.3	152.3	89.6	289.5	289.5
+ Total Debt	297.4	219.1	430.0	468.8	468.8
Enterprise Value	—	—	—	—	3,620.5
Net Debt (memo)	112.1	66.9	340.4	179.3	179.3
EV per Share	—	—	—	—	514.27

Total Capital	2,732.7	2,581.6	2,880.6	3,186.2	3,186.2
Total Debt/Total Capital	10.88	8.49	14.93	14.71	14.71
Total Debt/EV	—	—	—	—	0.13

EV/Sales	—	—	—	—	1.57
EV/EBITDA	—	—	—	—	15.84
EV/EBIT	—	—	—	—	34.38
Reference Items — Trailing FY Values
Sales	1,343.0	1,704.9	2,111.0	2,201.9	2,307.9
EBITDA	-45.6	100.2	264.9	184.2	228.6
EBIT	-159.0	-13.0	140.3	59.1	105.3
Operating Cash Flow	-85.1	16.7	-7.0	3.6	—
Free Cash Flow	-129.4	-5.9	-144.4	-119.4	-119.4
FCFF (free cash flow to the firm)	-129.4	-5.9	-146.5	-122.8	—
Capital Expenditure	44.3	22.5	137.4	123.0	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.